Infinium Global Research Pre Filled Syringes Market | Page 3

Pre Filled Syringes Market: Trends and Forecast -2023
primary challenges face by this market involves manufacturing of pre filled syringes
and stringent government regulations.
Segment Covered
The report on global pre filled syringes market covers segments such as, product
type, therapeutic category and design. On the basis of product type the global pre
filled syringes market is categorized into glass pre filled syringes and plastic pre
filled syringes. On the basis of therapeutic category the global pre filled syringes
market is categorized into insulin pre filled syringes, vaccine pre filled syringes,
arthritis pre filled syringes, heparin pre filled syringes, pcsk9 inhibitor pre filled
syringes and others pre filled syringes. On the basis of design the global pre filled
syringes market is categorized into single-chamber prefilled syringes, dual-chamber
prefilled syringes and customized prefilled syringes.
Geographic Coverage
The report provides regional analysis covering geographies such as North America,
Europe, Asia-Pacific, and Rest of the World. In this section the key trends and
market size for each geography is provided over the period of 2015-2023. The
countries covered in the North America region include the U.S., Canada, and
Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and
among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are
included in the European region. The U.S. drives the growth in the North America
region as it is the largest market in the region. The Asia-pacific region offers a
substantial potential for the market growth owing to rapid growth in markets such
as India and China. The APAC region is projected to experience a growth at a CAGR
of x.x% over the period of 2017-2023.
Major Key Players Mentioned in this Premium Report
The report provides profiles of the companies in the global pre filled syringes
market such as, Becton, Dickinson and Company, Baxter International Inc, Niulife
Corporation, Consort Medical plc, Ypsomed Holding AG, Nipro Corporation, West
Pharmaceutical Services, Inc, SCHOTT AG, SHL Group and Haselmeier AG.
3
© Infinium Global Research